VCH-916

CAS No. 1200133-34-1

VCH-916( —— )

Catalog No. M23370 CAS No. 1200133-34-1

VCH-916 is a new nonnucleoside inhibitor of HCV NS5B polymerase.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 98 In Stock
5MG 140 In Stock
10MG 185 In Stock
25MG 341 In Stock
50MG 550 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    VCH-916
  • Note
    Research use only, not for human use.
  • Brief Description
    VCH-916 is a new nonnucleoside inhibitor of HCV NS5B polymerase.
  • Description
    VCH-916 is a new nonnucleoside inhibitor of HCV NS5B polymerase.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Microbiology/Virology
  • Target
    HCV
  • Recptor
    NS5B polymerase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1200133-34-1
  • Formula Weight
    497.73
  • Molecular Formula
    C26H36KNO4S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:36 mg/mL (72.33 mM)
  • SMILES
    O=C(C1=C(N([C@H]2CC[C@H](OC)CC2)C([C@H]3CC[C@H](C)CC3)=O)C=C(C4=CCCCC4)S1)O[K]
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Abdelrahman S. Mayhoub. Hepatitis C RNA-dependent RNA polymerase inhibitors: A review of structure-activity and resistance relationships; different scaffolds and mutations. Bioorganic & Medicinal Chemistry. 2012, 20 (10): 3150-3161.
molnova catalog
related products
  • 7-benzyl-5,6-dimethy...

    Oxytetracycline (OTC) is a broad-spectrum antibiotic that acts by inhibiting protein synthesis in D2401bacteria.

  • Betaxolol

    Betaxolol is a selective beta1 adrenergic receptor blocker used in the treatment of hypertension and glaucoma.

  • Ciluprevir

    Ciluprevir (BILN2061) is a potent HCV NS3/4A protease inhibitor with Ki of 0.66 and 0.30 nM for NS3-NS4A protease of HCV 1b and HCV 1a, respectively.